Comparison of the ear outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer

Journal of Clinical Oncology

Volumn 17, Issue 2, 1999, Pages 517-522

  Chauvet, B ^a  

^a llnstitut Sainte Catherine   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN; RADIOACTIVE IODINE;

ADULT; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ERECTILE DYSFUNCTION; HUMAN; IMPLANTATION; IMPOTENCE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; TREATMENT OUTCOME; WELLBEING; ADENOCARCINOMA; AGED; ANIMAL; BRACHYTHERAPY; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; KIDNEY DISEASE; METHODOLOGY; MICTURITION DISORDER; MIDDLE AGED; MORBIDITY; MOUSE; PROSTATE TUMOR; RADIATION INJURY;

ADENOCARCINOMA; AGED; ANIMALS; BRACHYTHERAPY; DISEASE-FREE SURVIVAL; HUMANS; IMPOTENCE; IODINE RADIOISOTOPES; KIDNEY DISEASES; MALE; MICE; MIDDLE AGED; MORBIDITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; TREATMENT OUTCOME; URINATION DISORDERS;

EID: 0032588023     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.2.517     Document Type: Article

References (24)

1. Kupelian P, Katcher J, Levin H, et al: External beam radiotherapy versus radical prostatectomy for clinical stage T1-T2 prostate cancer: Therapeutic implications of stratification by pretreatment PSA levels and biopsy gleason scores. Cancer J Sci Am 3:78-87, 1997
2. D'Amico AV, Whittington R, Kaplan I, et al: Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4 > 20 ng/ml. Int J Radiat Oncol Biol Phys 37:1053-1058, 1997
3. D'Amico AV, Whittington R, Malkowicz SB, et al: Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969-974, 1998
4. Wallner K, Roy J, Harrison L: Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol 14:449-453, 1996
5. Blasko JC, Wallner K, Grimm PD, et al: Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma. J Urol 154:1096-1099, 1995
6. Stock RG, Stone NN: The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapy. Semin Surg Oncol 13:454-460, 1997
7. Beyer DC, Priestley JB: Biochemical disease-free survival following 1-125 prostate implantation. Int J Radiat Oncol Biol Phys 37:559-563, 1997
8. Zelefsky MJ, Leibel SA, Gaudin PB, et al: Dose escalation with three dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 41:491-500, 1998
9. American Joint Committee on Cancer: Prostate, in Beahrs OH, Henson DE, Hutter RVP, et al (eds): Manual for Staging of Cancer (ed 4). Philadelphia, PA, Lippincott, 1992, pp 181-183
10. Zelefsky MJ, Leibel SA, Kutcher GJ, et al: Three-dimensional conformal radiotherapy and dose escalation: Where do we stand? Semin Radiat Oncol 8:107-114, 1998
11. Zelefsky MJ, Leibel SA, Burman CA, et al: Neoadjuvant hormonal therapy improves the therapeutic ratio in patients with bulky prostatic cancer treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 29:755-761, 1994
12. Roy JN, Wallner KE, Chiu-Tsao S, et al: CT-based optimizedplanning for transperineal prostate implant with customized template. Int J Radiat Oncol Biol Phys 29:755-761, 1991
13. Wallner K, Roy J, Zelefsky MJ, et al: Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. Int J Radiat Oncol Biol Phys 29:863-868, 1994
14. American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 37:1035-1041, 1997
15. Lawton CA, Won M, Pilepich MV, et al: Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: Analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 21:935-936, 1991
16. Kaplan EL, Meier P: Nonparametic estimation from incomplete observations. J Am Stat Assoc 53:447-457, 1958
17. Mantel N: Evaluation of survival data and two rank order statistics arising in its consideration. Cancer Chemo Rep 50:163-168, 1966
18. Cox DR: Regression models and life tables. J R Stat Soc Series B 34:187-220, 1972
19. Kleinberg L, Wallner K, Roy J, et al: Treatment-related symptoms during the first year following transperineal I-125 prostate implantation. Int J Radiat Oncol Biol Phys 28:985-990, 1994
20. Arterberry VE, Wallner K, Roy J, et al: Short-term morbidity from CT-planned transperinral I-125 prostate implants. Int J Radiat Oncol Biol Phys 25:661-667, 1993
21. Wallner KE, Roy J, Harrison L, et al: Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32:465-471, 1995
22. Stock RG, Stone NN, Iannuzzi C: Sexual potency following interactive ultrasound guided brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys 35:267-272, 1996
23. Ragde H, Blasko JC, Grimm PD, et al: Brachytherapy for clinically localized prostate cancer: Results at 7-and 8-year follow-up. Semin Surg Oncol 13:438-443, 1997
24. Ling CC, Burman C, Chui CS, et al: Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulaled photon beams produced with multileaf collimation. Int J Radiat Oncol Biol Phys 35:721-730, 1996